{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:38:44Z","timestamp":1793709524456,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014726","name":"National Institute for Innovation in Manufacturing Biopharmaceuticals","doi-asserted-by":"publisher","award":["Project Award Agreement"],"award-info":[{"award-number":["Project Award Agreement"]}],"id":[{"id":"10.13039\/100014726","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000161","name":"National Institute of Standards and Technology","doi-asserted-by":"publisher","award":["70NANB21H086"],"award-info":[{"award-number":["70NANB21H086"]}],"id":[{"id":"10.13039\/100000161","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Biotechnology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.nbt.2026.10.002","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T14:19:48Z","timestamp":1791123588000},"page":"107-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessing the sustainability of fed-batch and continuous process formats for monoclonal antibody manufacturing via bioprocess modeling"],"prefix":"10.1016","volume":"96","author":[{"given":"Benjamin T.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvenna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Jungnelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"D\u2019Aquila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Connell-Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbt.2026.10.002_bib1","unstructured":"I.P. o C. Change, Climate change 2023 synthesis report summary for policymakers 2024."},{"key":"10.1016\/j.nbt.2026.10.002_bib2","unstructured":"United NationsThe Paris Agreement [Online]. Available: https:\/\/unfccc.int\/process-and-meetings\/the-paris-agreement. [Accessed 7 February 2024]."},{"key":"10.1016\/j.nbt.2026.10.002_bib3","unstructured":"US Department of Energy, \"Industrial Decarbonization Roadmap. DOE\/EE-2635. September 2022. Washington, DC\". https:\/\/www.energy.gov\/sites\/default\/files\/2022-09\/Industrial%20Decarbonization%20Roadmap.pdf."},{"issue":"2","key":"10.1016\/j.nbt.2026.10.002_bib4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.tibtech.2024.10.007","article-title":"Advancing biopharmaceutical manufacturing: economic and sustainability assessment of end-to-end continuous production of monoclonal antibodies","volume":"43","author":"Partopour","year":"2025","journal-title":"Trends Biotechnol"},{"issue":"4","key":"10.1016\/j.nbt.2026.10.002_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.2492","article-title":"Integrated continuous bioprocessing: economic, operational, and environmental feasibility for clinical and commercial antibody manufacture","volume":"33","author":"Pollock","year":"2017","journal-title":"Biotechnol Progress"},{"issue":"9","key":"10.1016\/j.nbt.2026.10.002_bib6","first-page":"1721","article-title":"A common framework for integrated and continuous biomanufacturing","volume":"118","author":"Coffman","year":"2021","journal-title":"no"},{"issue":"119","key":"10.1016\/j.nbt.2026.10.002_bib7","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1002\/bit.28234","article-title":"Process design of a fully integrated continuous biopharmaceutical process using economic and ecological impact assessment","volume":"119","author":"Ding","year":"2022","journal-title":"Biotechnol Bioeng"},{"issue":"9","key":"10.1016\/j.nbt.2026.10.002_bib8","first-page":"3302","article-title":"End-to-end collaboration to transform biopharmaceutical development and manufacturing","volume":"118","author":"Erickson","year":"2021"},{"key":"10.1016\/j.nbt.2026.10.002_bib9","volume":"2006","author":"ISO 14044","year":"2006"},{"issue":"3","key":"10.1016\/j.nbt.2026.10.002_bib10","first-page":"40","article-title":"An environmental life cycle assessment of single-use and conventional process technology: comprehensive environmental impacts","volume":"27","author":"Flanagan","year":"2014","journal-title":"BioPharm Int"},{"key":"10.1016\/j.nbt.2026.10.002_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jclepro.2012.09.048","article-title":"An environmental life cycle assessment comparison of single-use and conventional process technology for the production of monoclonal antibodies","volume":"41","author":"Pietrzykowski","year":"2013","journal-title":"J Clean Prod"},{"issue":"5","key":"10.1016\/j.nbt.2026.10.002_bib12","article-title":"Life-cycle and cost of goods assessment of fed-batch and perfusion-based manufacturing processes for mAbs","volume":"32","author":"Bunnak","year":"2016"},{"key":"10.1016\/j.nbt.2026.10.002_bib13","doi-asserted-by":"crossref","unstructured":"K. Budzinski, M. Blewis, P. Dahlin, D. D'Aquila, J. Esparza, J. Gavin, , \"Introduction of a process mass intensity metric for biologics,\" no. 49:37-42, 2019. https:\/\/doi.org\/10.1016\/j.nbt.2018.07.005.","DOI":"10.1016\/j.nbt.2018.07.005"},{"key":"10.1016\/j.nbt.2026.10.002_bib14","doi-asserted-by":"crossref","unstructured":"S. Argoud, K. Budzinski, D. D'Aquila, S.R. Madabhushi and P. Smith, \"Green metrics for biologics,\" vol. 35, 2022. https:\/\/doi.org\/10.1016\/j.cogsc.2022.100614.","DOI":"10.1016\/j.cogsc.2022.100614"},{"key":"10.1016\/j.nbt.2026.10.002_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbt.2022.11.002","article-title":"Comparison of process mass intensity (PMI) of continuous and batch manufacturing processes for biologics","volume":"72","author":"Madabhushi","year":"2022","journal-title":"New Biotechnol"},{"key":"10.1016\/j.nbt.2026.10.002_bib16","series-title":"Improving energy efficiency in a pharmaceutical manufacturing environment -- production facility","author":"Zhang","year":"2009"},{"key":"10.1016\/j.nbt.2026.10.002_bib17","article-title":"Energy efficiency improvement and cost saving opportunities for the pharmaceutical industry","author":"Galitsky","year":"2008","journal-title":"Ernest Orlando Lawrence Berkeley Natl Lab"},{"issue":"5","key":"10.1016\/j.nbt.2026.10.002_bib18","article-title":"Energy benchmarking in the pharmaceutical industry","volume":"33","author":"Capparella","year":"2013","journal-title":"Pharm Eng"},{"key":"10.1016\/j.nbt.2026.10.002_bib19","unstructured":"D. D\u2019Aquila, \"Benchmarking Biopharma's Carbon Footprint,\" 2017. https:\/\/www.pharmamanufacturing.com\/facilities\/water-waste\/article\/11310104\/benchmarking-biopharmas-carbon-footprint."},{"key":"10.1016\/j.nbt.2026.10.002_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.enbuild.2019.109346","article-title":"Energy demand reduction in pharmaceutical cleanrooms through optimization of ventilation","volume":"202","author":"Loomans","year":"2019","journal-title":"Energy Build"},{"issue":"4","key":"10.1016\/j.nbt.2026.10.002_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.5731\/pdajpst.2019.010660","article-title":"Risk-based selection of environmental classifications for biopharmaceutical operations","volume":"75","author":"Bevan","year":"2021","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.nbt.2026.10.002_bib22","doi-asserted-by":"crossref","unstructured":"M. Gabriela, B.T. Smith, B. Connors, M. Leslie, A. Hartwick, K. Gant, , \"Environmental sustainability assessment as a driver for selection of the manufacturing processes of a bispecific T-cell engager,\" Reaction Chemistry & Engineering, vol. 9, pp. 2773-2783. https:\/\/doi.org\/10.1039\/D4RE00266K.","DOI":"10.1039\/D4RE00266K"},{"key":"10.1016\/j.nbt.2026.10.002_bib23","first-page":"13","article-title":"Chapter 2 - circular economy and life cycle management","author":"Faul","year":"2025","journal-title":"Sustain Manuf Pharm"},{"key":"10.1016\/j.nbt.2026.10.002_bib24","unstructured":"D. D\u2019Aquila, B. Dillon, B. Flanagan, A. Fisher, B.T. Smith, N. Jungnelius, , Environmental Impact of Fed Batch vs. Continuous Monoclonal Antibody Manufacturing Using a Life Cycle Assessment Tool (in preparation)."}],"container-title":["New Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678426001147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678426001147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:18:41Z","timestamp":1793708321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871678426001147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":24,"alternative-id":["S1871678426001147"],"URL":"https:\/\/doi.org\/10.1016\/j.nbt.2026.10.002","relation":{},"ISSN":["1871-6784"],"issn-type":[{"value":"1871-6784","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the sustainability of fed-batch and continuous process formats for monoclonal antibody manufacturing via bioprocess modeling","name":"articletitle","label":"Article Title"},{"value":"New Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbt.2026.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}